Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Connective Tissue Cell Types01:22

Connective Tissue Cell Types

3.3K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

9.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

26
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
26
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

43
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
43
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

29
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
29
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

30
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
30

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Belimumab outperforms placebo for attainment of modified DORIS remission and LLDAS without the glucocorticoid component: a post hoc analysis of five phase III SLE trials.

RMD open·2026
Same author

Maternal diet shapes neonatal microbiome ontogenesis and neurometabolic resilience.

Gut microbes·2026
Same author

Reply.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Introduction to the issue: Cellular therapies in rheumatology.

Best practice & research. Clinical rheumatology·2026
Same author

Predictive correlates of arthritis and joint damage in systemic lupus erythematosus: a multinational prospective cohort study.

Rheumatology (Oxford, England)·2026
Same author

Patient-Friendly Real-Time Optical Tomographic Imaging System (LOTIS) for Lupus Arthritis.

Biosensors·2026

Related Experiment Video

Updated: Aug 19, 2025

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
06:31

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Published on: October 6, 2023

2.3K

Telerheumatology: A Narrative Review.

Wei Tang1, Leila Khalili1, Anca Askanase1

  • 1Department of Medicine, Division of Rheumatology, Columbia University Irving Medical Center, New York, NY 10032, USA.

Rheumatology and Immunology Research
|December 5, 2022
PubMed
Summary

Telemedicine in rheumatology, including telerheumatology (TR), offers improved access but faces limited research on acceptance and effectiveness. Key barriers to widespread TR implementation were identified.

Keywords:
rheumatoid arthritisrheumatologysystemic lupus erythematosustelemedicine

More Related Videos

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

329
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

296

Related Experiment Videos

Last Updated: Aug 19, 2025

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
06:31

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Published on: October 6, 2023

2.3K
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

329
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

296

Area of Science:

  • Rheumatology
  • Digital Health
  • Healthcare Delivery

Background:

  • Telemedicine (TM) has been utilized in rheumatology for over 20 years to enhance patient access and care.
  • The COVID-19 pandemic accelerated the shift from in-person visits to TM for rheumatology care, prioritizing safety.
  • Limited literature exists on the acceptance, feasibility, and effectiveness of TM in managing rheumatic diseases.

Purpose of the Study:

  • To review recent publications on telerheumatology (TR) applications in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE).
  • To assess patient and physician perceptions of TM in rheumatology.
  • To identify key barriers hindering the implementation of TR.

Main Methods:

  • Literature review of recent publications on TR in RA and SLE management.
  • Assessment of patient and physician perceptions regarding TM in rheumatology.
  • Identification and analysis of barriers to TR adoption.

Main Results:

  • TR has been applied in the management of Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE).
  • Patient and physician perceptions of TM in rheumatology were evaluated.
  • Several significant barriers to the effective implementation of TR were identified.

Conclusions:

  • While TM and TR offer potential benefits for rheumatology care, further research is needed on their acceptance, feasibility, and effectiveness.
  • Understanding and addressing identified barriers is crucial for successful TR implementation.
  • Guidance for integrating TR into patient care and clinical trials remains limited.